NVST ENVISTA HOLDINGS CORP
2026Q1 · CUSIP 29415F104 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
385
Δ holders QoQ
+51
Breadth percentile
Top 4%
Whale holders
170
Δ whales
+8
Inst. holding value
$4.4B
New positions
93
Closed positions
42
Price momentum (1Q)
-17.5%
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 4% | — | — |
| 2025Q3 | Top 12% | +50.3% | +24.4% |
| 2022Q1 | Top 5% | -7.9% | -12.0% |
| 2021Q2 | Top 5% | +6.4% | +15.1% |
| 2021Q1 | Top 13% | -9.7% | -3.9% |
| 2020Q4 | Top 8% | +15.9% | +4.7% |
| 2020Q3 | Top 13% | +29.5% | +52.0% |
| 2019Q4 | Top 2% | -44.3% | -16.5% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
2
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
64.8
EPS (TTM)
$0.41
EPS YoY
—
Revenue (TTM)
$2.8B
Revenue YoY
+12.2%
Net margin
2.4%
ROE
2.2%
Debt ratio
44.8%
FCF (TTM)
$220M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-04-03 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.